250 related articles for article (PubMed ID: 792355)
1. Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice.
Gadebusch HH; Pansy F; Klepner C; Schwind R
J Infect Dis; 1976 Nov; 134(5):423-7. PubMed ID: 792355
[TBL] [Abstract][Full Text] [Related]
2. Comparative chemotherapeutic activity of amphotericin B and amphotericine B methy ester.
Bonner DP; Tewari RP; Solotorovsky M; Mechlinski W; Schaffner CP
Antimicrob Agents Chemother; 1975 Jun; 7(6):724-9. PubMed ID: 1155916
[TBL] [Abstract][Full Text] [Related]
3. In vitro antifungal activity of BMS-181184 against systemic isolates of Candida, Cryptococcus, and Blastomyces species.
Karlowsky JA; Zhanel GG; Balko TV; Zelenitsky SA; Kabani AM; Hoban DJ
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):179-82. PubMed ID: 9327245
[TBL] [Abstract][Full Text] [Related]
4. Systemic antifungal activity of pyrrolnitrin.
Gordee RS; Matthews TR
Appl Microbiol; 1969 May; 17(5):690-4. PubMed ID: 5785951
[TBL] [Abstract][Full Text] [Related]
5. [Further experimental data on clotrimazole: effectiveness against Cryptococcus neoformans, Sporothrix schenkii and Blastomyces dermatitidis Gilchrist].
Barfuss T; Seeliger HP; Plempel M
Mykosen; 1975 May; 18(5):221-32. PubMed ID: 1099444
[No Abstract] [Full Text] [Related]
6. A9145, a new adenine-containing antifungal antibiotic. II. Biological activity.
Gordee RS; Butler TF
J Antibiot (Tokyo); 1973 Aug; 26(8):466-70. PubMed ID: 4600794
[No Abstract] [Full Text] [Related]
7. Evaluation of systemic antifungal agents in X-irradiated mice.
Gordee RS; Matthews TR
Appl Microbiol; 1970 Oct; 20(4):624-9. PubMed ID: 5498613
[TBL] [Abstract][Full Text] [Related]
8. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; García-Cambero JP; Zaragoza O
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
[TBL] [Abstract][Full Text] [Related]
9. In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating.
Petit C; Chéron M; Joly V; Rodrigues JM; Bolard J; Gaboriau F
J Antimicrob Chemother; 1998 Dec; 42(6):779-85. PubMed ID: 10052902
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous infection with Blastomyces dermatitidis and Cryptococcus neoformans.
Mounts A; Deepe GS
Med Mycol; 1998 Feb; 36(1):47-50. PubMed ID: 9776812
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo studies on synergistic antifungal activity.
Shadomy S
Contrib Microbiol Immunol; 1977; 4():147-57. PubMed ID: 342191
[No Abstract] [Full Text] [Related]
12. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
Hoeprich PD; Huston AC
J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
[TBL] [Abstract][Full Text] [Related]
13. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
Chen HH; Liushih RN; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
[TBL] [Abstract][Full Text] [Related]
14. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
Costa AL; Valenti A; Costa G; Calogero F
G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
[TBL] [Abstract][Full Text] [Related]
15. The in-vivo activity of an antifungal antibiotic, benanomicin A, in comparison with amphotericin B and fluconazole.
Ohtsuka K; Watanabe M; Orikasa Y; Inouye S; Uchida K; Yamaguchi H; Kondo S; Takeuchi T
J Antimicrob Chemother; 1997 Jan; 39(1):71-7. PubMed ID: 9044030
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B.
Parmegiani RM; Loebenberg D; Antonacci B; Yarosh-Tomaine T; Scupp R; Wright JJ; Chiu PJ; Miller GH
Antimicrob Agents Chemother; 1987 Nov; 31(11):1756-60. PubMed ID: 3324961
[TBL] [Abstract][Full Text] [Related]
17. The influence of antifungal antibiotics on some determinants of virulence in Candida albicans and Cryptococcus neoformans cells.
Borowski J; Jakoniuk P; Jablońska W; Jakubicz W; Szpak A
Experientia; 1974 Oct; 30(10):1210-1. PubMed ID: 4611784
[No Abstract] [Full Text] [Related]
18. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
Al Jalali V; Sauermann R; Eberl S; Zeitlinger M
Infection; 2019 Aug; 47(4):565-570. PubMed ID: 30725316
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates.
Thanathanee O; Miller D; Ringel DM; Schaffner CP; Alfonso EC; O'Brien TP
J Ocul Pharmacol Ther; 2012 Dec; 28(6):589-92. PubMed ID: 22788845
[TBL] [Abstract][Full Text] [Related]
20. Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice.
Hamilton JD; Elliott DM
J Infect Dis; 1975 Feb; 131(2):129-37. PubMed ID: 1090685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
